Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 4, Pages e586-e586
Publisher
Springer Nature
Online
2013-04-11
DOI
10.1038/cddis.2013.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma
- (2012) Simona Coco et al. INTERNATIONAL JOURNAL OF CANCER
- Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest
- (2012) Max M van Noesel LANCET ONCOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCFβ-TRCP in neuroblastoma cells
- (2011) Akanksha Singh et al. CANCER
- HOXC9 Links Cell-Cycle Exit and Neuronal Differentiation and Is a Prognostic Marker in Neuroblastoma
- (2011) L. Mao et al. CANCER RESEARCH
- The Master Negative Regulator REST/NRSF Controls Adult Neurogenesis by Restraining the Neurogenic Program in Quiescent Stem Cells
- (2011) Z. Gao et al. JOURNAL OF NEUROSCIENCE
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma
- (2010) S. Ackermann et al. CLINICAL CANCER RESEARCH
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells
- (2010) T R Daniels et al. LEUKEMIA
- Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
- (2010) A Oberthuer et al. PHARMACOGENOMICS JOURNAL
- HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
- (2009) L Plowright et al. BRITISH JOURNAL OF CANCER
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
- (2009) M Fischer et al. ONCOGENE
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P
- (2008) Liesl Shears et al. JOURNAL OF UROLOGY
- MicroRNAs in the Hox network: an apparent link to posterior prevalence
- (2008) Soraya Yekta et al. NATURE REVIEWS GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started